🔎 Trials Near Me

Domov › Ulcerózna kolitída › New York

Klinické štúdie Ulcerózna kolitída v štáte New York

30 štúdií pre Ulcerózna kolitída hľadá účastníkov v zariadeniach v štáte New York.

Mestá v štáte New York

Oficiálny text štúdie (anglicky)

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

  • New York Gastroenterology Associates ( Site 0253), New York
Prebieha náborFáza 3
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06651281

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Westchester Putnam Gastroenterology PC, Carmel
  • Five Towns Gastroenterology, Cedarhurst
  • IMIDeology, Elmhurst
  • a 5 ďalších
Prebieha náborFáza 4
Vek 18 až 80 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06581328

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Ellipsis Research Group, Brooklyn
  • Smart Medical Research - Jackson Heights, Jackson Heights
  • Pioneer Clinical Research NY, New York
  • a 1 ďalších
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Albany
  • Xencor Investigative Site, Rochester
Prebieha náborFáza 1/2Vítaní zdravých dobrovoľníkov
Vek 18 až 75 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 037, New York
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-002, Albany
  • Site US-016, Rochester
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07845487

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

  • Intercity Gastroenterology, Fresh Meadows
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06979336

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • Westchester Putnam Gastroenterology, Carmel
  • Inflammatory Bowel Disease Center at NYU Langone, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • a 3 ďalších
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07196748

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  • Columbia University Medical Center, New York
Prebieha náborFáza 2/3
Vek 2 až 17 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Icahn School of Medicine at Mount Sinai, New York
  • New York Gastroenterology Associates, New York
  • Care Access - Yonkers, Yonkers
Prebieha náborFáza 3
Vek 18 až 70 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • NYU Langone Hospital - Long Island, Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • a 1 ďalších
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Digestive Disease Medicine of Central New York, Utica
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07186101

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Icahn School of Medicine at Mount Sinai, New York
Prebieha náborFáza 3
Vek 2 až 19 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT04844606

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • Stony Brook University, Stony Brook
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  • NYU Langone Health, New York
  • Weill Cornell Medical College- New York Presbyterian Hospital, New York
Prebieha náborFáza 4
Vek 18 až 65 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • MedTraits NY - Site Number: 8400045, Maspeth
  • Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
  • New York Gastroenterology Associates - Site Number: 8400009, New York
Prebieha náborFáza 3
Vek 16 až 80 · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07185009

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  • New York Gastroenterology Associates, New York
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT07577856

A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

  • Fink Children's Ambulatory Care Center, New York
  • Kimmel Pavilion - NYU Langone, New York
  • NYU Grossman School of Medicine, New York
  • a 4 ďalších
Prebieha náborFáza 2
Vek 2 až 11 · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT07470879

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

  • Columbia University Medical Center, New York
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 21. 8. 2026 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • MedTraits NY - Site Number: 8400045, Maspeth
  • Manhattan Clinical Research, LLC - Site Number: 8400069, New York
  • NYU Langone Health - Site Number: 8400091, New York
  • a 4 ďalších
Prebieha náborFáza 3
Vek 16 až 80 · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • Saratoga Schenectady Gastroenterology Associates, Burnt Hills
  • NYU Langone Health, New York
  • Cornell University, New York
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 8. 2026 · NCT05230173

BOOM-IBD2 Pivotal Clinical Trial

  • Northwell Health North Shore University Hospital, Manhasset
  • Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Prebieha nábor
Vek 18 až 85 · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT06571669

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • New York University, New York
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 8. 2026 · NCT07237516

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

  • NYU Langone Health, New York
  • Lenox Hill Hospital, Northwell Health, New York
Prebieha náborObservačná štúdia
Vek 18 až 64 · Všetky pohlavia · Aktualizované 9. 7. 2026 · NCT06398626

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • New York Presbyterian Hospital, New York
Prebieha náborFáza 3
Vek 2 až 17 · Všetky pohlavia · Aktualizované 22. 6. 2026 · NCT06405087

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, New York
  • Mirador Therapeutics Selected Site, Rochester
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 12. 3. 2026 · NCT07113522

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

  • State University of New York Upstate Medical University, Syracuse
Prebieha nábor
Vek 18 až 85 · Všetky pohlavia · Aktualizované 8. 1. 2026 · NCT05987852

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

  • Bausch Health Site 006, The Bronx
Prebieha náborFáza 4
Vek 5 až 17 · Všetky pohlavia · Aktualizované 16. 9. 2025 · NCT04314375

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

  • New York University, New York
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 5. 2025 · NCT06750731

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.